HALOZYME THERAPEUTICS INC. - US40637H1095 (Stock)
/IBT-BA-HP/WEB-INF/snippets/root/general/name.jsp
0
0
0
49,88 EUR
|
1,0944% |
25.07.2025 08:11
|
230,00 |
49,75 |
50,12 |
230,00 |
/IBT-BA-HP/WEB-INF/snippets/root/general/v2/infobar.jsp
0
0
0
/IBT-BA-HP/WEB-INF/snippets/root/general/toolbar.jsp
34
1
35
/IBT-BA-HP/WEB-INF/snippets/root/stock/navigation.jsp
33
1
34
Balance ratios |
2023 |
2022 |
Total assets |
- |
- |
Employees |
- |
- |
Cash and cash equivalents |
- |
- |
Intangible / inalienable assets |
- |
- |
Economic shareholder's equity |
- |
- |
Subscribed Capital |
- |
- |
Liabilities |
- |
- |
Liabilities to financial institutions |
- |
- |
GuV Zahlen |
2023 |
2022 |
Sales |
- |
- |
Profit after tax |
- |
- |
Deprecation (??) |
- |
- |
Dividend ordinary shares |
- |
- |
Net investment income |
- |
- |
Dividend preferred shares |
- |
- |
Net interests income |
- |
- |
Earnings from ordinary operating activities |
- |
- |
Net income (after minority interests) |
- |
- |
Net earnings per share |
- |
- |
Total payout |
- |
- |
Administrative expenses |
- |
- |